Ad
related to: how to correct hyperphosphatemia in children treatment at home health servicesagingcare.com has been visited by 100K+ users in the past month
- In Home Care Locator
Use our Home Care Agency Locator
to find local agencies near you
- Speak To An Advisor Today
Our service is always free. Get
free home care advice today.
- Compare Costs & Services
Get free estimates and compare care
options on price and availability.
- Senior Caregivers Near Me
Share your care needs and get local
options to compare. Search today.
- In Home Care Locator
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms.
Children with Special Healthcare Needs (CSHCN) are defined by the Maternal and Child Health Bureau as: "Those who have one or more chronic physical, developmental, behavioral, or emotional conditions and who also require health and related services of a type or amount beyond that required by children generally" [1]
Phosphate binder. Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.
Sucroferric oxyhydroxide. Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). [6] It is used in form of chewable tablets.
Home health aide visits per 60-day episode of home care declined by 90% from 1998 to 2019, from an average of about 13 visits per episode to just one, according to MedPAC (the Medicare Payment ...
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer ...
Advocates say the problems faced at these schools are emblematic of the severe mental health crisis among youths in Michigan, and point to a greater need for behavioral health interventions, one ...
Renal osteodystrophy is currently defined as an alteration of bone morphology in patients with chronic kidney disease (CKD). [1] It is one measure of the skeletal component of the systemic disorder of chronic kidney disease-mineral and bone disorder (CKD-MBD). [1][2][3] The term "renal osteodystrophy" was coined in 1943, [4] 60 years after an ...
Ad
related to: how to correct hyperphosphatemia in children treatment at home health servicesagingcare.com has been visited by 100K+ users in the past month